Introduction: Pain of endodontic origin is of concern to both the patient and the clinician. Expectation of a painful experience can increase the patient's anxiety levels, making treatment more difficult. Management of endodontic pain is one of the challenging aspects in endodontics.
INTRODUCTION
Interappointment pain is an unavoidable sequel to endodontic treatment. Causative factors include mechanical, chemical, and microbial injuries to the pulp and the periradicular tissues that are induced or exacerbated by root canal treatment. Onset of pain may be within few hours and lasts up to 48 h. [1, 2] Anxiety, apprehension, fear of dental treatment, and other psychological factors influence the patients' pain perception and reaction thresholds. [2] A correlation has been indicated between the presence of apprehension before endodontic treatment and postoperative pain. [3, 4] Literature reveals that nearly 80% of the patients reporting with a complaint of preoperative pain also experienced severe postoperative pain. [5] Overinstrumentation, periapical extrusion of irrigant/medicament, and restoration in hyperocclusion are chief causes that often provoke an acute inflammatory response, resulting in a mid-treatment flare-up. [4, [6] [7] [8] Anti-inflammatory analgesics, systemic steroids, and anxiolytics are few of the commonly used preoperative drugs used during endodontic practice. [9] Pretreatment analgesia has been defined as an antinociceptive treatment that prevents altered processing of afferent input amplifying postoperative pain. [10] This technique may decrease the establishment of central sensitization, a mechanism whereby spinal neurons increase their responsiveness to peripheral nociceptive input. [11] The purpose of this clinical trial is to evaluate the analgesic efficacy of diclofenac sodium administered through various routes in reducing postendodontic pain.
MATERIALS AND METHODS
Ethical approval was obtained from the ethical committee of the university. Thirty patients who visited the postgraduate clinic in the department of conservative dentistry and endodontics were enrolled in the study after assessing the criteria for inclusion. The research was approved by the institutional review board according to the national and international specifications.
Criteria for inclusion:
• Vital pulp in need of endodontic therapy • Irreversible pulpitis in molar teeth • Age -18-65 years.
Criteria for exclusion:
• History of systemic diseases • History of allergy to nonsteroidal anti-inflammatory drugs (NSAIDs) • Radiographic evidence of periapical pathosis • Pregnant or lactating mothers.
Medical history was recorded and only those patients with no history of systemic illness were considered for this clinical trial. Pulp vitality was determined using thermal testing -heat and cold -followed by an electric pulp tester. Informed consent was obtained from the patients in both English and the regional language in which they were familiar with. The patients who fulfilled all the criteria for inclusion were then randomly divided into three groups by a sequentially numbered, opaque, sealed envelope method.
• Group A -Placebo (Vitamin B12 tablets) -Neurobion Forte • Group B -Intraligamentary route of diclofenac sodium (Voveran) • Group C -Oral diclofenac sodium (Voveran 75 mg).
Based on the groups assigned, the patients in Groups A and C were given tablets 30 min before the commencement of endodontic therapy while patients assigned to Group B were administered intraligamentary injection before commencing the procedure.
All the patients were anesthetized with standard injections 1.8 ml of 2% lidocaine containing 1:80000 epinephrine. The tooth was isolated with the help of a rubber dam. Access opening was done with a Endo-Access Bur (Dentsply Maillefer, Ballaigues, Switzerland), and after locating the orifices, the working lengths were determined for each individual canal with an electronic apex locator (Root ZX, Morita, Tokyo, Japan). The canals were instrumented using Gates Glidden Drills, stainless steel hand K-files, and ProTaper rotary files (Dentsply Maillefer, Ballaigues, Switzerland). All canals were enlarged to the size of a #25 file and continuously irrigated using 3% sodium hypochlorite. The canals were dried with paper points, and calcium hydroxide (RC Cal, Prime Dental) was applied as a medicament for 7 days. Endodontic treatment was performed by the same endodontist. The visual analog scale was used to measure the pain level at baseline and 6, 12, 24, and 48 h postoperatively. A rescue prescription of analgesic (paracetamol 500 mg) was prescribed, and the patients were instructed to take it if they experienced pain and inform the reviewer while assessing the pain score. The intensity of pain after treatment was recorded by a blinded reviewer and was statistically analyzed. 
Statistical analysis

RESULTS
The age, gender, mean initial VAS scores, and tooth type were tabulated, and there were no significant differences (P > 0.05) among the three groups [ Table 4 ].
The results showed that there was a statistical difference in the reduction of pain score among the three groups and 
DISCUSSION
Perception of pain is highly subjective and influenced by many factors, which make the precise definition of different discomfort categories and detailed description of pain difficult. [12] While pain during therapy is usually controlled by local anesthesia, postoperative pain control is often and may contribute to the development of hyperalgesia leading to increase in pain later. [13, 14] Pain control in endodontic patients should be efficacious with minimum side effects. Posttreatment pain in endodontics had been reported to occur in 25%-40% of all endodontic patients. [11] Most of the investigators have found that there is a strong relationship between preoperative and postoperative pain. [4, 15, 16] Evaluation of pain intensity was done using the verbal descriptor scale as well as visual analog scale ranged from 0 to 10. [17] Patients who experienced moderate-to-severe pain were included as preoperative pain has been established as a major determinant of postoperative pain or flare-up. [1, 18] Most of the patients experienced pain in the first 24 h after initiation of root canal treatment. [4] Therefore, 48 h period for assessment was chosen in this study even though the drugs tested would not be expected to provide ongoing analgesia for this entire period owing to their relative short plasma half-lives.
Endodontic treatment can cause the release of inflammatory mediators into the surrounding periapical tissues. [19] Thus, pain fibers are directly stimulated or sensitized by prostaglandins in situ. [20] In addition, the vascular dilation and increased permeability as consequences of periradicular inflammation cause edema and increased interstitial tissue response. [19] Considering the role of prostaglandins on endodontic pain, a possible strategy for reduction of postoperative endodontic pain might be the local use of an anti-inflammatory agents adjacent to the inflamed tooth to decrease the production of inflammatory mediators [19, 21] and improve the efficacy of local anesthetics.
Various methods have been advocated to reduce pain, namely opioids, glucocorticoids, long-acting local anesthetics, and NSAIDs. For pain of moderate intensity, NSAIDs are prescribed. Diclofenac sodium is a NSAID that acts by inhibition of prostaglandin synthesis by inhibition of cyclooxygenase pathway. It also exhibits bacteriostatic action by inhibition of bacterial DNA synthesis. [22] The onset of action of diclofenac sodium is 10 min, and as the drug persists in the tissue fluids for 11 h, the action of a single dose is for 6-8 h, which is the half-life of the drug. [23] Anesthetizing tooth with irreversible pulpitis poses a challenge as the voltage-gated sodium channels are resistant to local anesthetic relatively. [24] Sodium channels are sensitized by prostaglandins that suggest that pretreatment administration increases the efficacy of local anesthetic in patients with odontogenic pain. [25, 26] Prostaglandins lower the activation threshold and increase the flow of sodium ions in the channel by sensitization of the tetrodotoxin-resistant channels. [27] Oral route of diclofenac sodium administration is known to cause gastrointestinal problems; thus, intraligamentary injection helps overcome this side effect. [24] The intraligamentary route helps bypass the first-pass metabolism in the liver; thus, the availability of the drug is 100% at the odontogenic region while the bioavailability of the oral route of administration is around 50% due to the first-pass metabolism in the liver. Combination of inferior alveolar nerve block and intraligamentary injection of diclofenac sodium helps in significantly reducing pain due to the anti-inflammatory action of the drug that helps in reducing the inflammatory mediators, thereby reducing the pain. [24] Intraligamentary injections pose the risk of prolonged ischemia of the interdental papilla, followed by sloughing and exposure of the crestal bone along with swelling and discoloration of the soft tissues. [11, 28] No such complication was experienced during the course of this study.
Pain intensity was evaluated using the visual analog scale as this scale has been used in most of the previous studies that analyzed pain after endodontic treatment. [4, 6, [29] [30] [31] Limitations of the visual analog scale included providing it on paper or electronically. The failure of VAS is between 4% and 11%, but it can be eliminated if the tool is carefully explained to the patients. [30, 32] Further research must be undertaken with a larger sample size and by comparing with other NSAIDs by the routes of administration to zero in on the drug and mode of administration for effective interappointment pain relief in endodontic treatment.
CONCLUSION
Within the limitations of this study, it can be concluded that diclofenac sodium is effective in allaying the endodontic pain experienced by the patients and intraligamentary route of delivery is more efficacious in abating pain for up to 48 h.
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